Docs / API reference

Search medicines

GET/v1/drugs

Searches every record of every source in one country by name, active ingredient or identifier. Names match anywhere in the text; identifiers such as AIC, CN, NDC or DIN codes match from their first character. Matching ignores accents and case. Results rank exact matches first, then prefix matches, then other matches, each by record name.

Parameters

country string Required
Two-letter ISO 3166-1 country code, lowercase. Every search is scoped to one country.
q string Required
The text to search for: a name, an active ingredient or an identifier. 3 to 120 characters, matched literally.
limit integer
Number of results to return, from 1 to 50. Defaults to 20.
offset integer
Number of results to skip, from 0 to 10000. Use the nextOffset of the previous page.
kinds string
Keep only these record kinds, as comma-separated sourceId:kind pairs of the requested country, at most 12. Applied before pagination.
useDomain enum
Keep only records whose source classifies them for this use. human and veterinary also include products the source marks for both. Applied before pagination.

Possible values: human veterinary both unknown not-applicable

species string
Keep only records with this reviewed target species, such as dog, cat, horse or cattle. Records with unknown or unmapped species are excluded. Applied before pagination.

Returns

country string
The country searched.
results Record[]
The matching records, best matches first.
nextOffset integer | null
The offset of the next page, or null on the last page.

Errors

400 401 403 429 503 · Errors and rate limits

GET /v1/drugs
curl -G https://api.medifontis.com/v1/drugs \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=de" \
  --data-urlencode "q=ozempic"
Response
{
  "country": "de",
  "results": [
    {
      "country": "de",
      "sourceId": "de.ema.article57",
      "id": "de:ema:article57:3f301c505c8d15200fcc",
      "kind": "products",
      "name": "Ozempic",
      "data": {
        "name": "Ozempic",
        "holder": "Novo Nordisk A/S",
        "routes": [
          "Subcutaneous Use"
        ],
        "marketed": null,
        "useDomain": "unknown",
        "databaseDate": "2026-10-09",
        "sourceStatus": null,
        "supplyRegime": null,
        "listingStatus": "listed-as-authorised",
        "targetSpecies": [],
        "sourceRowCount": 1,
        "activeSubstances": [
          "Semaglutide"
        ],
        "documentRevision": "90",
        "documentReference": "EMA/518502/2018",
        "useDomainEvidence": {
          "basis": "unreviewed",
          "field": null,
          "value": null,
          "version": 1,
          "sourceId": "de.ema.article57"
        },
        "patientEligibility": "not-assessed",
        "centrallyAuthorised": true,
        "targetSpeciesStatus": "not-reported",
        "activeSubstancesText": "Semaglutide",
        "administrativeStatus": "unknown",
        "prescriptionCategory": "unknown",
        "prescriptionRequired": null,
        "authorisationTerritory": "European Union",
        "pharmacovigilanceContacts": [
          {
            "email": "SOSPON@novonordisk.com",
            "phone": "+45 4444 8888",
            "masterFileLocation": "Denmark"
          }
        ]
      },
      "region": null,
      "retrievedAt": "2026-10-20T01:00:19.432Z",
      "sourceUrl": "https://www.ema.europa.eu/en/documents/other/article-57-product-data_en.xlsx",
      "licence": {
        "id": "LicenseRef-EMA-Legal-Notice",
        "url": "https://www.ema.europa.eu/en/about-us/legal-notice",
        "scope": "rows of EMA’s public Article 57 product data authorised in Germany or centrally in the European Union",
        "reviewedAt": "2026-09-29",
        "attribution": "Source: European Medicines Agency (EMA), Article 57 product data (EMA/518502/2018), based on data submitted by marketing-authorisation holders.",
        "documentsIncluded": false
      },
      "limitations": [
        "Germany has no free, complete official bulk medicine database with PZNs: BfArM’s AMIce public search is interactive only, its § 31b reference database is supplied to commercial users on request, and the GKV-Spitzenverband and BfArM price lists are PDF-only for reasons of usage rights.",
        "EMA’s Article 57 export names every medicinal product authorised in Germany (national, mutual-recognition and decentralised procedures) and every centrally authorised EU product, as submitted by marketing-authorisation holders; submissions can lag an authorisation change.",
        "A record is one product name, active-substance text, route and marketing-authorisation holder. Strengths, forms, packs, PZNs, authorisation numbers and dates are not published, so rows EMA lists more than once for one such product are kept together with their count.",
        "The export publishes no legal category (verschreibungspflichtig, apothekenpflichtig, freiverkäuflich), so the prescription classification stays unknown; listing is not proof of current authorisation, marketing, availability or reimbursement.",
        "Active-substance names are the English xEVMPD names EMA publishes, not German INN spellings.",
        "EMA’s legal notice permits commercial and non-commercial reproduction with acknowledgement of EMA as the source; its exception for third-party content leaves the status of holder-submitted text unconfirmed."
      ],
      "names": [
        "Ozempic",
        "Semaglutide"
      ],
      "identifiers": []
    }
  ],
  "nextOffset": null
}